PatientsVille.com Logo

PatientsVille

Glakay Side Effects

Common Glakay Side Effects

The most commonly reported Glakay side effects (click to view or check a box to report):

Pyrexia (6)
Pneumonia (5)
White Blood Cell Count Decreased (4)
Septic Shock (3)
Hypertension (3)
Cough (3)
Chest Pain (2)
Henoch-schonlein Purpura (2)
Aspartate Aminotransferase Increased (2)
Erythema Multiforme (2)
Hepatic Function Abnormal (2)
Decreased Appetite (2)
Chills (2)
Platelet Count Decreased (2)
Palmar-plantar Erythrodysaesthesia Syndrome (2)
Multi-organ Failure (2)
Pancytopenia (2)
Rash (2)
Renal Failure (2)
Serum Ferritin Increased (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Glakay Side Effects Reported to FDA

The following Glakay reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Glakay on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Febrile Neutropenia, Hypertension, Platelet Count Decreased, White Blood Cell Count Decreased, Serum Ferritin Increased, Neutrophil Count Decreased
on Jun 18, 2012 Male from JAPAN , weighting 149.9 lb, was treated with Glakay. Directly after, patient experienced the unwanted or unexpected Glakay side effects: febrile neutropenia, hypertension, platelet count decreased, white blood cell count decreased, serum ferritin increased, neutrophil count decreased. Glakay dosage: 45 Milligram.
Associated medications used:
  • Cefmetazole Sodium
  • Vidaza (75 Milligram/sq. Meter)
  • Vidaza (75 Milligram/sq. Meter)
  • Exjade
  • Decadron (4 Milligram)
  • Decadron (4 Milligram)
  • Decadron (4 Milligram)
  • Kytril (2 Milligram)
Patient was hospitalized.

Decreased Appetite, Nasopharyngitis, Somnolence
Patient was taking Glakay. Patient felt the following Glakay side effects: decreased appetite, nasopharyngitis, somnolence on May 28, 2012 from JAPAN Additional patient health information: Female , 91 years of age, weighting 35.01 lb, was diagnosed with and. Glakay dosage: N/A.
Multiple prescriptions taken:
  • Lasix
  • Kamag G
  • Menatetrenone
  • Bisolvon
  • Rabeprazole Sodium
  • Livalo
  • Galantamine Hydrobromide
  • Rocaltrol
Patient was hospitalized.

Renal Failure, Respiratory Failure, Septic Shock, Multi-organ Failure
Adverse event was reported on Mar 21, 2012 by a Male taking Glakay (Dosage: 15 Mg, Tid) . Location: JAPAN , weighting 119.0 lb, After Glakay was administered, patient encountered several Glakay side effects: renal failure, respiratory failure, septic shock, multi-organ failure.
Multiple concurrent drugs taken:
  • Asacol (Unk)
  • Famotidine (20 Mg, Uid/qd)
  • Miya Bm (2 Df, Tid)
  • Prednisolone (6.25 Mg, Bid)
  • Prograf (3 Mg, Bid)
  • Ferrous Citrate (2 Df, Uid/qd)
  • Loperamide Hcl (1 Mg, Uid/qd)


Pancytopenia
on Feb 16, 2012 Female from JAPAN , weighting 99.21 lb, was treated with Glakay. Directly after, patient experienced the unwanted or unexpected Glakay side effects: pancytopenia. Glakay dosage: N/A.
Associated medications used:
  • Fosrenol
  • Mircera
  • Cinacalcet Hydrochloride
  • Rabeprazole Sodium
  • Urso 250
  • Risumic (In Front Of Hd)
  • Wasser V
  • Lac-b
Patient was hospitalized.


Sepsis, Epistaxis, Cellulitis, Myelodysplastic Syndrome
on Jan 26, 2012 Female from JAPAN , weighting 141.1 lb, was treated with Glakay. Patient felt the following Glakay side effects: sepsis, epistaxis, cellulitis, myelodysplastic syndrome. Glakay dosage: N/A.
Multiple prescriptions taken:
  • Alfarol
  • Pursennid
  • Magnesium Sulfate
  • Vidaza (75 Milligram/sq. Meter)
  • Vfend
  • Ciprofloxacin
  • Mucodyne
  • Vidaza (37.5 Milligram/sq. Meter)
Patient was hospitalized.

Cerebral Haemorrhage, Fall, Speech Disorder
Patient was taking Glakay. After Glakay was administered, patient encountered several Glakay side effects: cerebral haemorrhage, fall, speech disorder on Nov 22, 2011 from JAPAN Additional patient health information: Female , weighting 92.59 lb, . Glakay dosage: 45 Mg, Unk.
Multiple concurrent drugs taken:
  • Cephadol (75 Mg, Unk)
  • Platibit (1 Ug, Unk)
  • Amlodipine Besylate/valsartan (1 Df, Daily)
Patient was hospitalized and became disabled.

Septic Shock, Pneumonia, White Blood Cell Count Decreased
Adverse event was reported on Sep 21, 2011 by a Male taking Glakay (Dosage: 45 Mg, Unk) was diagnosed with and. Location: JAPAN , weighting 132.3 lb, Directly after, patient experienced the unwanted or unexpected Glakay side effects: septic shock, pneumonia, white blood cell count decreased.
Associated medications used:
  • Diflucan
  • Amaryl (1 Mg, Unk)
  • Diflucan (200 Mg, Unk)
  • Exjade (1000 Mg, Daily)
  • Lasix (10 Mg, Unk)
  • Aldactone (12.5 Mg, Unk)
  • Red Blood Cells, Concentrated (2 Units (every Week))
Patient was hospitalized.

Inflammatory Marker Increased, Pyrexia, Liver Disorder
on Sep 13, 2011 Male from JAPAN , 62 years of age, weighting 125.7 lb, was treated with Glakay. Patient felt the following Glakay side effects: inflammatory marker increased, pyrexia, liver disorder. Glakay dosage: Daily Dose 45 Mg.
Multiple prescriptions taken:
  • Nizatidine (Daily Dose 300 Mg)
  • Lamivudine (Daily Dose 100 Mg)
  • Amoban (Daily Dose 5 Mg)
  • Nexavar (400 Mg, Bid)
  • Aldactone (Daily Dose 50 Mg)
  • Acetaminophen (Daily Dose 400 Mg)
  • Lasix (Daily Dose 20 Mg)
  • Loxonin (Daily Dose 60 Mg)
Patient was hospitalized.

Anaemia, Drowning, White Blood Cell Count Decreased, Mallory-weiss Syndrome, Hepatic Function Abnormal, Palmar-plantar Erythrodysaesthesia Syndrome, Hypertension
on Aug 24, 2011 Male from JAPAN , 65 years of age, weighting 119.0 lb, was treated with Glakay. After Glakay was administered, patient encountered several Glakay side effects: anaemia, drowning, white blood cell count decreased, mallory-weiss syndrome, hepatic function abnormal, palmar-plantar erythrodysaesthesia syndrome, hypertension. Glakay dosage: Since Before Administration.
Multiple concurrent drugs taken:
  • Allopurinol (Since Before Administration)
  • Fentanyl
  • Lansoprazole (15 Mg (daily Dose), , Oral)
  • Nexavar
  • Uralyt (Since Before Administration)
  • Fentanyl (Since Before Administration, 2.1/3mg)
  • Oxinorm (Since Before Administration)
  • Fentanyl (Since Before Administration, 4.2/3mg)


Ileus Paralytic, Constipation, Dysuria
Patient was taking Glakay. Directly after, patient experienced the unwanted or unexpected Glakay side effects: ileus paralytic, constipation, dysuria on Jul 20, 2011 from JAPAN Additional patient health information: Male , 64 years of age, . Glakay dosage: N/A.
Associated medications used:
  • Teleminsoft
  • Ondasetron
  • Vidaza (75 Milligram)
  • Alinamin-f
  • Vidaza (75 Milligram)
  • Magnesium Sulfate
  • Pantol
  • Primobolan
Patient was hospitalized.

White Blood Cell Count Decreased, Septic Shock, Pneumonia
Adverse event was reported on Apr 12, 2010 by a Male taking Glakay (Dosage: 45 Mg, Unk) was diagnosed with and. Location: JAPAN , weighting 132.3 lb, Patient felt the following Glakay side effects: white blood cell count decreased, septic shock, pneumonia.
Multiple prescriptions taken:
  • Exjade (100 Mg)
  • Amaryl (1 Mg, Unk)
  • Lasix (10 Mg, Unk)
  • Red Blood Cells, Concentrated (2 Units (every Week))
  • Aldactone (12.5 Mg, Unk)
  • Diflucan (200 Mg, Unk)
  • Diflucan
Patient was hospitalized.

Aspartate Aminotransferase Increased, Erythema Multiforme, Lip Erosion, Blood Creatine Phosphokinase Increased, Pyrexia, Alanine Aminotransferase Increased, Thrombocytopenia, Blood Albumin Decreased, Haemorrhage
on May 11, 2011 Male from JAPAN , 78 years of age, was treated with Glakay. After Glakay was administered, patient encountered several Glakay side effects: aspartate aminotransferase increased, erythema multiforme, lip erosion, blood creatine phosphokinase increased, pyrexia, alanine aminotransferase increased, thrombocytopenia, blood albumin decreased, haemorrhage. Glakay dosage: 45 Mg (daily Dose), , Oral.
Multiple concurrent drugs taken:
  • Urso 250 (600 Mg (daily Dose), , Oral)
  • Rabeprazole Sodium (10 Mg (daily Dose), , Oral)
  • Uft (300 Mg (daily Dose), , Oral)
  • Adjust-a (80 Mg (daily Dose), , Oral)
  • Livact (12.45 G (daily Dose), , Oral)
  • Falkamin (12.45 G (daily Dose), , Oral)
  • Magnesium Sulfate (1980 Mg (daily Dose), , Oral)
  • Nexavar
Patient was hospitalized.

Neoplasm Malignant, Pneumonia, Pruritus, Gamma-glutamyltransferase Increased, Pancytopenia, Oral Pain, Serum Ferritin Increased, Toxic Epidermal Necrolysis, Erythema Multiforme
on Mar 07, 2011 Female from JAPAN , weighting 99.21 lb, was diagnosed with and was treated with Glakay. Directly after, patient experienced the unwanted or unexpected Glakay side effects: neoplasm malignant, pneumonia, pruritus, gamma-glutamyltransferase increased, pancytopenia, oral pain, serum ferritin increased, toxic epidermal necrolysis, erythema multiforme. Glakay dosage: 45 Mg.
Associated medications used:
  • Primobolan (Unk)
  • Exjade (1000 Mg, Qd)
  • Red Blood Cells (2 U, Unk)
Patient was hospitalized.

Bronchitis, Bacterial Infection, Dehydration, Pyrexia, Multi-organ Failure, Cough, Blood Creatinine Increased, Renal Failure
Patient was taking Glakay. Patient felt the following Glakay side effects: bronchitis, bacterial infection, dehydration, pyrexia, multi-organ failure, cough, blood creatinine increased, renal failure on Mar 07, 2011 from JAPAN Additional patient health information: Female , weighting 88.18 lb, . Glakay dosage: 45 Mg, Unk.
Multiple prescriptions taken:
  • Exjade (500 Mg, Daily)
  • Neoral (100 Mg, Daily)
  • Desferal (500 Mg)
  • Neutrogin (2.50 Ug)
  • Clarithromycin (400 Mg)
  • Exjade (500 Mg Daily)
  • Neoral (75 Mg, Daily)
Patient was hospitalized.

Platelet Count Decreased, Haematocrit Decreased, Vomiting, Red Blood Cell Count Decreased, Haemoglobin Decreased, Nausea
Adverse event was reported on Feb 21, 2011 by a Female taking Glakay (Dosage: 45 Mg, Unk) was diagnosed with and. Location: JAPAN , weighting 110.2 lb, After Glakay was administered, patient encountered several Glakay side effects: platelet count decreased, haematocrit decreased, vomiting, red blood cell count decreased, haemoglobin decreased, nausea.
Multiple concurrent drugs taken:
  • Red Blood Cells, Concentrated (02 Units Each Time)
  • Nasanyl (02 Df, Unk)
  • Exjade (1000 Mg Daily)
  • Takepron (15 Mg, Unk)
  • Adona (90 Mg, Unk)
  • Alfarol (03 Df, Unk)
  • Blood Transfusion, Auxiliary Products (Unk)


Hypertension, Insomnia, Hepatic Function Abnormal, Pollakiuria, Pyrexia
on Dec 16, 2010 Male from JAPAN , weighting 125.7 lb, was treated with Glakay. Directly after, patient experienced the unwanted or unexpected Glakay side effects: hypertension, insomnia, hepatic function abnormal, pollakiuria, pyrexia. Glakay dosage: Before Nexavar Administration.
Associated medications used:
  • Mevalotin (Before Nexavar Administration)
  • Lendormin (0.25 Mg (daily Dose), , Oral)
  • Ursodeoxycholic Acid
  • Flivas (25 Mg (daily Dose), , Oral)
  • Allelock (Before Nexavar Administration)
  • Livact (Before Nexavar Administration)
  • Nexavar
  • Tryptanol (10 Mg (daily Dose), , Oral)


Hypoglycaemia, Palmar-plantar Erythrodysaesthesia Syndrome, Decreased Appetite
on Jan 14, 2011 Female from JAPAN , weighting 70.55 lb, was diagnosed with and was treated with Glakay. Patient felt the following Glakay side effects: hypoglycaemia, palmar-plantar erythrodysaesthesia syndrome, decreased appetite. Glakay dosage: Daily Dose 45 Mg.
Multiple prescriptions taken:
  • Gastrom (Daily Dose 3 G)
  • Celecoxib (Daily Dose 200 Mg)
  • Livact (Daily Dose 12.45 G)
  • Lacb-r (Daily Dose 3 G)
  • Omepral (Daily Dose 20 Mg)
  • Sorafenib (raf Kinase Inhibitor) (Daily Dose 800 Mg)
  • Lopemin (Daily Dose 2 Mg)
  • Tannalbin (Daily Dose 3 G)


Chest Pain, Chills, Cough, Henoch-schonlein Purpura, Pneumonia, Pyrexia, Rash
Patient was taking Glakay. After Glakay was administered, patient encountered several Glakay side effects: chest pain, chills, cough, henoch-schonlein purpura, pneumonia, pyrexia, rash on Feb 16, 2008 from JAPAN Additional patient health information: Male , 65 years of age, weighting 123.5 lb, was diagnosed with and. Glakay dosage: N/A.
Multiple concurrent drugs taken:
  • Alfarol
  • Niflan
  • Neo-minophagen C
  • Loxonin
  • Exjade (1125 Mg, Qd)
Patient was hospitalized.

Chest Pain, Chills, Cough, Henoch-schonlein Purpura, Pneumonia, Pyrexia, Rash
Adverse event was reported on Feb 16, 2008 by a Male taking Glakay (Dosage: N/A) was diagnosed with and. Location: JAPAN , 65 years of age, weighting 123.5 lb, Directly after, patient experienced the unwanted or unexpected Glakay side effects: chest pain, chills, cough, henoch-schonlein purpura, pneumonia, pyrexia, rash.
Associated medications used:
  • Alfarol
  • Niflan
  • Neo-minophagen C
  • Loxonin
  • Exjade (1125 Mg, Qd)
Patient was hospitalized.

Aspartate Aminotransferase Increased, Disease Recurrence, Gamma-glutamyltransferase Increased, Hepatitis C
on Nov 26, 2004 Female from , 66 years of age, was treated with Glakay. Patient felt the following Glakay side effects: aspartate aminotransferase increased, disease recurrence, gamma-glutamyltransferase increased, hepatitis c. Glakay dosage: 45 Mg, Unk.
Multiple prescriptions taken:
  • Urso 250 (600 Mg, Unk)
  • Cabagin-u (6 Df, Unk)
  • Diovan (40 Mg, Qd)
Patient was hospitalized.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Glakay Side Effects

    Did You Have a Glakay Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Glakay for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    More About Glakay

    Side Effects reported to FDA: 20

    Glakay safety alerts: No

    Reported deaths: 6

    Reported hospitalizations: 15

    Latest Glakay clinical trials

    Glakay Reviews

    No reviews, be a first to report a side effect via side effect reporting form